Chemical Name: (1R,1'R,2R,2'R,3R,3'R,5S,5'S)-5,5'-((2,7-bis(propylthio)pyrimido[4,5-g]pteridine-4,9-diyl)bis(azanediyl))bis(3-(2-hydroxyethoxy)cyclopentane-1,2-diol)
Smiles: CCCSC1=NC(N[C@@H]2[C@@H](O)[C@@H](O)[C@H](OCCO)C2)=C3C(N=C4C(N[C@@H]5[C@@H](O)[C@@H](O)[C@H](OCCO)C5)=NC(SCCC)=NC4=N3)=N1
Inchi: InChI=1S/C34H50N8O8S2/c1-7-13-51-31-39-27(35-17-15-19(45-11-9-43)25-23(17)47-33(3,4)49-25)21-29(41-31)37-22-28(40-32(52-14-8-2)42-30(22)38-21)36-18-16-20(46-12-10-44)26-24(18)48-34(5,6)50-26/h17-20,23-26,43-44H,7-16H2,1-6H3,(H,35,37,39,41)(H,36,38,40,42)/t17-,18-,19+,20+,23+,24+,25-,26-/m0/s1
Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method
By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.
From World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.
Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies
By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav
From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724
Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)
By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara
From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42